Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biomarkers of success of anti-PD-(L)1 immunotherapy for non-small cell lung cancer derived from RNA- and whole-exome sequencing: results of a prospective observational study on a cohort of 85 patients.
Poddubskaya E, Suntsova M, Lyadova M, Luppov D, Guryanova A, Lyadov V, Garazha A, Sorokin M, Semenova A, Shatalov V, Biakhova M, Simonov A, Moisseev A, Buzdin A. Poddubskaya E, et al. Among authors: sorokin m. Front Immunol. 2024 Dec 12;15:1493877. doi: 10.3389/fimmu.2024.1493877. eCollection 2024. Front Immunol. 2024. PMID: 39723204 Free PMC article.
Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer.
Gudkov A, Shirokorad V, Kashintsev K, Sokov D, Nikitin D, Anisenko A, Borisov N, Sekacheva M, Gaifullin N, Garazha A, Suntsova M, Koroleva E, Buzdin A, Sorokin M. Gudkov A, et al. Among authors: sorokin m. Front Mol Biosci. 2022 Mar 14;9:753318. doi: 10.3389/fmolb.2022.753318. eCollection 2022. Front Mol Biosci. 2022. PMID: 35359606 Free PMC article.
Large-scale assessment of pros and cons of autopsy-derived or tumor-matched tissues as the norms for gene expression analysis in cancers.
Sorokin M, Buzdin AA, Guryanova A, Efimov V, Suntsova MV, Zolotovskaia MA, Koroleva EV, Sekacheva MI, Tkachev VS, Garazha A, Kremenchutckaya K, Drobyshev A, Seryakov A, Gudkov A, Alekseenko IV, Rakitina O, Kostina MB, Vladimirova U, Moisseev A, Bulgin D, Radomskaya E, Shestakov V, Baklaushev VP, Prassolov V, Shegay PV, Li X, Poddubskaya EV, Gaifullin N. Sorokin M, et al. Comput Struct Biotechnol J. 2023 Aug 3;21:3964-3986. doi: 10.1016/j.csbj.2023.07.040. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 37635765 Free PMC article.
Pan-cancer experimental characteristic of human transcriptional patterns connected with telomerase reverse transcriptase (TERT) gene expression status.
Drobyshev A, Modestov A, Suntsova M, Poddubskaya E, Seryakov A, Moisseev A, Sorokin M, Tkachev V, Zakharova G, Simonov A, Zolotovskaia MA, Buzdin A. Drobyshev A, et al. Among authors: sorokin m. Front Genet. 2024 May 27;15:1401100. doi: 10.3389/fgene.2024.1401100. eCollection 2024. Front Genet. 2024. PMID: 38859942 Free PMC article.
Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels.
Sorokin M, Ignatev K, Barbara V, Vladimirova U, Muraveva A, Suntsova M, Gaifullin N, Vorotnikov I, Kamashev D, Bondarenko A, Baranova M, Poddubskaya E, Buzdin A. Sorokin M, et al. Biochemistry (Mosc). 2020 Jul;85(7):758-772. doi: 10.1134/S0006297920070044. Biochemistry (Mosc). 2020. PMID: 33040720 Free article. Clinical Trial.
Bioinformatic and clinical experimental assay uncovers resistance and susceptibility mechanisms of human glioblastomas to temozolomide and identifies new combined and individual survival biomarkers outperforming MGMT promoter methylation.
Modestov A, Zolotovskaia M, Suntsova M, Zakharova G, Seryakov A, Jovcevska I, Mlakar J, Poddubskaya E, Moisseev A, Vykhodtsev G, Roumiantsev S, Sorokin M, Tkachev V, Simonov A, Buzdin A. Modestov A, et al. Among authors: sorokin m. Ther Adv Med Oncol. 2024 Nov 8;16:17588359241292269. doi: 10.1177/17588359241292269. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39525666 Free PMC article.
157 results